Abiopharma

CF INDUSTRIES HOLDINGS, INC. (CF) Reports the reporting period Financial Results CF INDUSTRIES HOLDINGS, INC. (CF) announced its financial results for the period ending the reporting period. Key Financial Highlights:

• Revenue: 4683
• Net Income: 131.33
• EPS: $3.99
• Cash and equivalents: 2042
  • anticipated by these forward-looking statements will occur, and if any of the events do occur, there is no guarantee what effect they will have on our business, results of operations, cash flows, financial condition and future prospects. Forward-looking statements are given only as of the date of this communication and the Company disclaims any obligation to update or revise the forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.For additional information:MediaInvestorsChris CloseDarla RiveraSenior Director, Corporate CommunicationsDirector, Investor Relations847-405-2542
  • expected in the near- and medium-term as global nitrogen trade requires time to rebalance.Secure North American nitrogen availability: Management believes nitrogen channel inventory in North America is at average levels as domestic and imported supply has been moving through the supply chain since July 2025